Keith J. Chappell - Concepedia

Author

Keith J. Chappell

Also Known As

, K. Chappell, K. J. Chappell, K.J. Chappell, Keith Joseph Chappell, Keith Chappell, Keith J Chappell, Keith J. Chappell, Keith Joseph Chappell

107

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

The University of Queensland The University of Melbourne Peter Doherty Institute Australian National University The Pirbright Institute

About

Keith J. Chappell is an author at The University of Queensland specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	1.1K
2	Natural Sciences	7	7	406
3	Public Health	3	3	78
4	Allergy	2	2	284
5	Engineering	1	1	14

Keith J. Chappell

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention Margarita Magro, Vicente Más, Keith J. Chappell, Proceedings of the National Academy of Sciences Respiratory Virus ImmunityImmunologyViral PathogenesisViral Structural ProteinImmunotherapy	2012	265
Systems serology detects functionally distinct coronavirus antibody features in children and elderly Kevin J. Selva, Carolien E. van de Sandt, Melissa M. Lemke, Nature Communications	2021	172
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein Eduardo A. Albornoz, Alberto A. Amarilla, Naphak Modhiran, Molecular Psychiatry	2022	164
Structure of West Nile Virus NS3 Protease: Ligand Stabilization of the Catalytic Conformation Gautier Robin, Keith J. Chappell, Martin J. Stoermer, Journal of Molecular Biology Virus StructureMolecular VirologyBiochemistryProtein FoldingCatalytic Conformation	2008	146
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial Keith J. Chappell, Francesca L. Mordant, Zheyi Li, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccine DevelopmentImmunologyMedicine	2021	117
A broadly protective antibody that targets the flavivirus NS1 protein Naphak Modhiran, Hao Song, Lidong Liu, Science	2021	116
Enzymatic Characterization and Homology Model of a Catalytically Active Recombinant West Nile Virus NS3 Protease Tessa Nall, Keith J. Chappell, Martin J. Stoermer, Journal of Biological Chemistry	2004	112
The piRNA Response to Retroviral Invasion of the Koala Genome Tianxiong Yu, Birgit S. Koppetsch, Sara Pagliarani, Cell BiologyPirna ResponseNatural SciencesGeneticsRna Biology	2019	107
Insights to Substrate Binding and Processing by West Nile Virus NS3 Protease through Combined Modeling, Protease Mutagenesis, and Kinetic Studies Keith J. Chappell, Martin J. Stoermer, David P. Fairlie, Journal of Biological Chemistry	2006	91
Potent Cationic Inhibitors of West Nile Virus NS2B/NS3 Protease With Serum Stability, Cell Permeability and Antiviral Activity Martin J. Stoermer, Keith J. Chappell, Susann Liebscher, Journal of Medicinal Chemistry	2008	83

Page 1